Endurant Capital Management LP Nevro Corp Transaction History

Endurant Capital Management LP

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$141.6 - $179.06 $912,187 - $1.15 Million	-6,442 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$132.81 - $182.18 $855,562 - $1.17 Million	6,442 New	6,442 $899,000
Q3 2019 Nov 14, 2019	SELL	$61.52 - $91.1 $3.9 Million - $5.78 Million	-63,394 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$58.04 - $66.99 $3.68 Million - $4.25 Million	63,394 New	63,394 $4.11 Million
Q1 2019 May 15, 2019	SELL	$35.52 - $62.62 $1.95 Million - $3.44 Million	-54,977 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$35.43 - $56.29 $1.09 Million - $1.73 Million	30,806 Added 127.45%	54,977 $2.14 Million
Q3 2018 Nov 14, 2018	BUY	$44.22 - $75.47 $622,396 - $1.06 Million	14,075 Added 139.41%	24,171 $1.38 Million
Q2 2018 Aug 14, 2018	SELL	$72.38 - $92.5 $43,789 - $55,962	-605 Reduced 5.65%	10,096 $806,000
Q1 2018 May 15, 2018	SELL	$69.46 - $88.57 $1.13 Million - $1.44 Million	-16,260 Reduced 60.31%	10,701 $927,000
Q4 2017 Feb 14, 2018	SELL	$65.94 - $93.31 $824,250 - $1.17 Million	-12,500 Reduced 31.68%	26,961 $1.86 Million
Q3 2017 Nov 14, 2017	BUY	$80.87 - $91.08 $3.19 Million - $3.59 Million	39,461	39,461 $3.59 Million

151

39.3M

67.9K

1.59M

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $134M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Endurant Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Endurant Capital Management LP with notifications on news.